Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDX (Metadoxine) in Adults with ADHD (MEASURE)
NCT02477748Phase 3Terminated
- Sponsor
- Alcobra Ltd.
- Start
- Jun 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Metadoxine in attention deficit hyperactivity disorder (ADHD), sponsored by Alcobra Ltd.. Started Jun 2015; status: terminated.
02
Drugs
Metadoxine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02477748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477748.